Abstract 5162: Effects of combined epigenetic therapy with histone methyltransferase EZH2 inhibitor 3-deazaneplanocin and histone deacetylase inhibitor SAHA on non-small cell lung cancer cells
2015 ◽
Vol 94
(2)
◽
pp. 79-90
◽
2010 ◽
Vol 101
(6)
◽
pp. 1424-1430
◽
2017 ◽
Vol 4
(1)
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7279-7279
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7279-7279